Supreme Court blocks Purdue Pharma settlement that would shield Sackler family

Supreme Court blocks Purdue Pharma settlement that would shield Sackler family




Purdue Pharma’s opioid settlement sparks backlash

Purdue Pharma’s opioid settlement sparks backlash


Washington — The Supreme Court on Thursday temporarily blocked a nationwide settlement with OxyContin maker Purdue Pharma that would shield members of the Sackler family who own the company from civil lawsuits over the toll of opioids.

The justices agreed to a request from the Biden administration to put the brakes on an agreement reached last year with state and local governments. In addition, the high court will hear arguments before the end of the year over whether the settlement can proceed.

The deal would allow the company to emerge from bankruptcy as a different entity, with its profits used to fight the opioid epidemic. Members of the Sackler family would contribute up to $6 billion.

But a key component of the agreement would shield family members, who are not seeking bankruptcy protection as individuals, from lawsuits.

The U.S. Bankruptcy Trustee, represented by the Justice Department, opposes releasing the Sackler family from legal liability.

The justices directed the parties to address whether bankruptcy law authorizes a blanket shield from lawsuits filed by all opioid victims. The 2nd U.S. Circuit Court of Appeals had allowed the reorganization plan to proceed.

In a filing with the Supreme Court, Solicitor General Elizabeth Prelogar said that if the lower court’s decision is allowed to stand, it would provide a “roadmap for wealthy corporations and individuals to misuse the bankruptcy system to avoid mass tort liability.”

“That is not what Congress enacted the Bankruptcy Code to accomplish,” she told the justices. “And if such abuses are permitted, the gamesmanship that is sure to follow will only amplify the harms to victims by redistributing bargaining power to tortfeasors.”

Lawyers for Purdue and other parties to the agreement had urged the justices to stay out of the case. “This is a baseless stay application that, if granted, would harm victims and needlessly delay the distribution of billions of dollars to abate the opioid crisis,” Purdue’s lawyers wrote.

Ed Neiger, a lawyer representing individual victims of the opioid crisis who would be in line for a piece of the settlement, said it was a disappointment that they would have to wait longer for any compensation but also praised the court for agreeing to hear the case so soon. “They clearly see the urgency of the matter,” he said.

Another group of mostly parents of people who died from opioid overdoses has called for the settlement not to be accepted.

Opioids have been linked to more than 70,000 fatal overdoses annually in the U.S. in recent years. Most of those are from fentanyl and other synthetic drugs. But the crisis widened in the early 2000s as OxyContin and other powerful prescription painkillers became prevalent.

Thanks for reading CBS NEWS.

Create your free account or log in
for more features.

Please enter email address to continue

Please enter valid email address to continue

Read More